{
    "A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses": "7822889",
    "A Multivalent and Thermostable Nanobody Neutralizing SARS-CoV-2 Omicron (B.1.1.529)": "9869787",
    "A Na\u00efve Phage Display Library-Derived Nanobody Neutralizes SARS-CoV-2 and Three Variants of Concern": "10588750",
    "A Potent Neutralizing Nanobody Targeting the Spike Receptor-Binding Domain of SARS-CoV-2 and the Structural Basis of Its Intimate Binding": "9158119",
    "A VHH single-domain platform enabling discovery and development of monospecific antibodies and modular neutralizing bispecifics against SARS-CoV-2 variants": "11200683",
    "A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo": "8748511",
    "A broad neutralizing nanobody against SARS-CoV-2 engineered from an approved drug": "11211474",
    "A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice": "8899823",
    "A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies": "8448731",
    "A comprehensive overview of recent advances in generative models for antibodies": "11254834",
    "A humanized nanobody phage display library yields potent binders of SARS CoV-2 spike": "9365158",
    "A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variants": "10251734",
    "A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants": "8564274",
    "A novel bispecific antibody dual-targeting approach for enhanced neutralization against fast-evolving SARS-CoV-2 variants": "10562541",
    "A novel strategy for an anti-idiotype vaccine: nanobody mimicking neutralization epitope of porcine circovirus type 2": "10878242",
    "A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron": "9257560",
    "A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19": "8458290",
    "A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants": "8863326",
    "A potent synthetic nanobody with broad-spectrum activity neutralizes SARS-CoV-2 virus and the Omicron variant BA.1 through a unique binding mode": "9479348",
    "Accelerating PERx reaction enables covalent nanobodies for potent neutralization of SARS-CoV-2 and variants": "9288967",
    "Accurate predictions of SARS-CoV-2 infectivity from comprehensive analysis": "11668528",
    "Advances and Challenges in Antiviral Development for Respiratory Viruses": "11768830",
    "Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19": "9016159",
    "Allosteric Determinants of the SARS-CoV-2 Spike Protein Binding with Nanobodies: Examining Mechanisms of Mutational Escape and Sensitivity of the Omicron Variant": "8877688",
    "An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models": "9924070",
    "An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction": "7473855",
    "An in silico method to assess antibody fragment polyreactivity": "9729196",
    "An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformation": "7430568",
    "An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants": "8828845",
    "An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike": "7857409",
    "Anti-SARS-CoV-1 and \u22122 nanobody engineering towards avidity-inspired therapeutics": "8608585",
    "Antibody-mediated immunity to SARS-CoV-2 spike": "9393763",
    "Antibody-mediated spike activation promotes cell-cell transmission of SARS-CoV-2": "10664894",
    "Applications of nanobodies in the prevention, detection, and treatment of the evolving SARS-CoV-2": "9801699",
    "Aptamers and Nanobodies as New Bioprobes for SARS-CoV-2 Diagnostic and Therapeutic System Applications": "10968798",
    "Arsenal of nanobodies shows broad-spectrum neutralization against SARS-CoV-2 variants of concern in vitro and in vivo in hamster models": "9461429",
    "Atomistic Simulations and In Silico Mutational Profiling of Protein Stability and Binding in the SARS-CoV-2 Spike Protein Complexes with Nanobodies: Molecular Determinants of Mutational Escape Mechanisms": "8515575",
    "Avidity engineering of human heavy-chain-only antibodies mitigates neutralization resistance of SARS-CoV-2 variants": "9990171",
    "Biomimetic Nanotechnology for SARS-CoV-2 Treatment": "10051120",
    "Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5": "9822811",
    "Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2": "9529347",
    "Biparatopic sybodies neutralize SARS\u2010CoV\u20102 variants of concern and mitigate drug resistance": "8982573",
    "Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern": "8651051",
    "Bispecific antibodies with broad neutralization potency against SARS-CoV-2 variants of concern": "11100608",
    "Bridging the Gap: Can COVID-19 Research Help Combat African Swine Fever?": "10536364",
    "Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and Synthetic Library Screening": "10373554",
    "Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2": "11277385",
    "Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses": "9792944",
    "Camel nanobodies broadly neutralize SARS-CoV-2 variants": "8575140",
    "Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumours": "10517151",
    "Changes within the P681 residue of spike dictate cell fusion and syncytia formation of Delta and Omicron variants of SARS-CoV-2 with no effects on neutralization or infectivity": "10238279",
    "Circular RNA vaccines against SARS-CoV-2 and emerging variants": "8971115",
    "Comparison of a SARS-CoV-2 mRNA booster immunization containing additional antigens to a spike-based mRNA vaccine against Omicron BA.5 infection in hACE2 mice": "11614295",
    "Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants": "11209230",
    "Computational Protein Design for COVID-19 Research and Emerging Therapeutics": "10042144",
    "Computational design and engineering of self-assembling multivalent microproteins with therapeutic potential against SARS-CoV-2": "10858482",
    "Cross protection to SARS-CoV-2 variants in hamsters with naturally-acquired immunity": "10386765",
    "Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2": "10013841",
    "De novo design of a stapled peptide targeting SARS-CoV-2 spike protein receptor-binding domain": "10507807",
    "Deep mutational engineering of broadly-neutralizing nanobodies accommodating SARS-CoV-1 and 2 antigenic drift": "9132424",
    "Development and characterization of a novel nanobody with SRMV neutralizing activity": "10858559",
    "Development of a bispecific nanobody conjugate broadly neutralizes diverse SARS-CoV-2 variants and structural basis for its broad neutralization": "10688893",
    "Development of a highly specific and sensitive VHH-based sandwich immunoassay for the detection of the SARS-CoV-2 nucleoprotein": "8526496",
    "Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein": "7844813",
    "Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis": "8223476",
    "Discovery and multimerization of cross-reactive single-domain antibodies against SARS-like viruses to enhance potency and address emerging SARS-CoV-2 variants": "10444775",
    "Discovery of Nanosota-9 as anti-Omicron nanobody therapeutic candidate": "11630572",
    "Discovery of Nanosota-EB1 and -EB2 as Novel Nanobody Inhibitors Against Ebola Virus Infection": "11723632",
    "Discovery of Therapeutic Antibodies Targeting Complex Multi-Spanning Membrane Proteins": "11530565",
    "Discovery of nanobodies: a comprehensive review of their applications and potential over the past five years": "11515141",
    "Distinct Conformations of SARS-CoV-2 Omicron Spike Protein and Its Interaction with ACE2 and Antibody": "9967551",
    "Dromedary camel nanobodies broadly neutralize SARS-CoV-2 variants": "9170159",
    "Efficient virus detection utilizing chitin-immobilized nanobodies synthesized in Ustilago maydis": "10028217",
    "Emerging Landscape of Nanobodies and Their Neutralizing Applications against SARS-CoV-2 Virus": "10275483",
    "Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy": "8537675",
    "Emerging trends in point-of-care biosensing strategies for molecular architectures and antibodies of SARS-CoV-2": "9941073",
    "Engineered Multivalent Nanobodies Efficiently Neutralize SARS-CoV-2 Omicron Subvariants BA.1, BA.4/5, XBB.1 and BQ.1.1": "11054741",
    "Enhanced Assessment of Cross-Reactive Antigenic Determinants within the Spike Protein": "11311977",
    "Enhancing antibody affinity through experimental sampling of non-deleterious CDR mutations predicted by machine learning": "10636138",
    "Epitope profiling using computational structural modelling demonstrated on coronavirus-binding antibodies": "8700021",
    "Evaluation of an Affinity-Enhanced Anti-SARS-CoV2 Nanobody Design Workflow Using Machine Learning and Molecular Dynamics": "11481066",
    "Expanding and improving nanobody repertoires using a yeast display method: Targeting SARS-CoV-2": "9884143",
    "Extracellular modulation of TREK-2 activity with nanobodies provides insight into the mechanisms of K2P channel regulation": "11099193",
    "Facilitating and restraining virus infection using cell-attachable soluble viral receptors": "11551432",
    "Fortuitous somatic mutations during antibody evolution endow broad neutralization against SARS-CoV-2 Omicron variants": "10154539",
    "Fragment-based computational design of antibodies targeting structured epitopes": "9651861",
    "Fully synthetic platform to rapidly generate tetravalent bispecific nanobody-based immunoglobulins": "10268213",
    "Generation of nanobodies from transgenic \u2018LamaMice\u2019 lacking an endogenous immunoglobulin repertoire": "11148044",
    "Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape": "8651292",
    "Host cell membrane proteins located near SARS-CoV-2 spike protein attachment sites are identified using proximity labeling and proteomic analysis": "9492400",
    "Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy": "8837488",
    "Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infection": "10265947",
    "Identification of nurse shark VNAR single-domain antibodies targeting the spike S2 subunit of SARS-CoV-2": "10715488",
    "Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development": "10985062",
    "In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies": "8232969",
    "Isolation, characterization, and structure-based engineering of a neutralizing nanobody against SARS-CoV-2": "9020654",
    "LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants": "9035363",
    "Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain": "8463300",
    "Leveraging Artificial Intelligence to Expedite Antibody Design and Enhance Antibody-Antigen Interactions": "10886287",
    "Lys417 acts as a molecular switch that regulates the conformation of SARS-CoV-2 spike protein": "10695562",
    "Mapping Potential Antigenic Drift Sites (PADS) on SARS-CoV-2 Spike in Continuous Epitope-Paratope Space": "8202428",
    "Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography": "8677774",
    "Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy": "8193598",
    "Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection": "8724751",
    "Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern": "8782626",
    "Mucosal nanobody IgA as inhalable and affordable prophylactic and therapeutic treatment against SARS-CoV-2 and emerging variants": "9512078",
    "Multi-epitope vaccine against SARS-CoV-2 targeting the spike RBD: an immunoinformatics approach": "11140640",
    "Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice": "9258422",
    "Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralizing SARS-CoV-2 nanobodies": "8956255",
    "Murine alveolar macrophages rapidly accumulate intranasally administered SARS-CoV-2 Spike protein leading to neutrophil recruitment and damage": "10954308",
    "Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission": "8776496",
    "NABP-BERT: NANOBODY\u00ae-antigen binding prediction based on bidirectional encoder representations from transformers (BERT) architecture": "11650500",
    "NanoNet: Rapid and accurate end-to-end nanobody modeling by deep learning": "9411858",
    "Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron": "9082315",
    "Nanobodies against SARS-CoV-2 reduced virus load in the brain of challenged mice and neutralized Wuhan, Delta and Omicron Variants": "10054972",
    "Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants": "8260353",
    "Nanobodies with cross-neutralizing activity provide prominent therapeutic efficacy in mild and severe COVID-19 rodent models": "10590698",
    "Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2": "8043454",
    "Nanobody against SARS-CoV-2 non-structural protein Nsp9 inhibits viral replication in human airway epithelia": "11401216",
    "Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice": "8126837",
    "Nanobody engineering for SARS-CoV-2 neutralization and detection": "10986514",
    "Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus": "11076045",
    "Nanobody screening and machine learning guided identification of cross-variant anti-SARS-CoV-2 neutralizing heavy-chain only antibodies": "11793827",
    "Nanobody-peptide-conjugate (NPC) for passive immunotherapy against SARS-CoV-2 variants of concern (VoC): a prospective pan-coronavirus therapeutics": "9676808",
    "Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological and pathological disease in a Syrian hamster model of COVID-19": "8597880",
    "Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological, and pathological disease in a Syrian hamster model of COVID-19": "8928829",
    "Neutralisation resistance of SARS-CoV-2 spike-variants is primarily mediated by synergistic receptor binding domain substitutions": "11562025",
    "Neutralization of SARS\u2010CoV\u20102 by highly potent, hyperthermostable, and mutation\u2010tolerant nanobodies": "8420576",
    "Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies": "10301551",
    "NeutrobodyPlex-monitoring SARS\u2010CoV\u20102 neutralizing immune responses using nanobodies": "8097376",
    "Next-Generation Molecular Discovery: From Bottom-Up In Vivo and In Vitro Approaches to In Silico Top-Down Approaches for Therapeutics Neogenesis": "8950575",
    "Outlook of therapeutic and diagnostic competency of nanobodies against SARS-CoV-2: A systematic review": "8730734",
    "Outsmarting pathogens with antibody engineering": "10330301",
    "Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants": "9043892",
    "Perspective on therapeutic and diagnostic potential of camel nanobodies for coronavirus disease-19 (COVID-19)": "7820838",
    "Perturbation of the host cell Ca2+ homeostasis and ER-mitochondria contact sites by the SARS-CoV-2 structural proteins E and M": "10148623",
    "Plasmodium infection is associated with cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein": "9778468",
    "Potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins": "10294592",
    "Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination": "10847457",
    "Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody": "7870875",
    "Prediction of polyreactive and nonspecific single-chain fragment variables through structural biochemical features and protein language-based descriptors": "9720949",
    "Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development": "7443330",
    "Prospects for the computational humanization of antibodies and nanobodies": "11133524",
    "Prospects of Neutralizing Nanobodies Against SARS-CoV-2": "8194341",
    "Protein-protein and protein-nucleic acid binding site prediction via interpretable hierarchical geometric deep learning": "11528319",
    "Quantitative flow cytometric selection of tau conformational nanobodies specific for pathological aggregates": "10445546",
    "Quantitative profiling of N-glycosylation of SARS-CoV-2 spike protein variants": "10114651",
    "Rapid and Quantitative In-vitro Evaluation of SARS-CoV-2 Neutralizing Antibodies and Nanobodies": "9356539",
    "Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries": "8726723",
    "Research progress of spike protein mutation of SARS-CoV-2 mutant strain and antibody development": "11609190",
    "Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies": "10060843",
    "Robust anti-SARS-CoV2 single domain antibodies cross neutralize multiple viruses": "9181070",
    "SARS-CoV-2 Specific Nanobodies Neutralize Different Variants of Concern and Reduce Virus Load in the Brain of h-ACE2 Transgenic Mice": "10892724",
    "SARS-CoV-2 Spike Protein Is Capable of Inducing Cell-Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies": "10384293",
    "SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein": "10615762",
    "SARS-CoV-2 spike fusion peptide trans interaction with phosphatidylserine lipid triggers membrane fusion for viral entry": "11389415",
    "SARS-CoV-2: Origin, Evolution, and Targeting Inhibition": "8248807",
    "Screening, Expression, and Identification of Nanobody against SARS-CoV-2 Spike Protein": "9656363",
    "Scrutinizing Coronaviruses Using Publicly Available Bioinformatic Tools: The Viral Structural Proteins as a Case Study": "8181738",
    "Sentinel cells enable genetic detection of SARS-CoV-2 Spike protein": "8077567",
    "Shark IgNAR: The Next Broad Application Antibody in Clinical Diagnoses and Tumor Therapies?": "10532743",
    "Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity": "9896449",
    "Single domain antibodies derived from ancient animals as broadly neutralizing agents for SARS-CoV-2 and other coronaviruses": "9482557",
    "Single-domain antibodies against SARS-CoV-2 RBD from a two-stage phage screening of universal and focused synthetic libraries": "10865538",
    "Status and Developing Strategies for Neutralizing Monoclonal Antibody Therapy in the Omicron Era of COVID-19": "10302031",
    "Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies": "7833398",
    "Structural Characterization of a Neutralizing Nanobody With Broad Activity Against SARS-CoV-2 Variants": "9201380",
    "Structural Insights into the Design of Synthetic Nanobody Libraries": "9000494",
    "Structural and Computational Studies of the SARS-CoV-2 Spike Protein Binding Mechanisms with Nanobodies: From Structure and Dynamics to Avidity-Driven Nanobody Engineering": "8951411",
    "Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants": "8853550",
    "Structural and functional characterization of nanobodies that neutralize Omicron variants of SARS-CoV-2": "11285730",
    "Structural basis of nanobodies neutralizing SARS-CoV-2 variants": "8908544",
    "Structural understanding of SARS-CoV-2 virus entry to host cells": "10683510",
    "Structure defining of ultrapotent neutralizing nanobodies against MERS-CoV with novel epitopes on receptor binding domain": "11324105",
    "Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19": "8771608",
    "Structure-Guided Development of Bivalent Aptamers Blocking SARS-CoV-2 Infection": "10303109",
    "Structure-based dual affinity optimization of a SARS-CoV-1/2 cross-reactive single-domain antibody": "8967028",
    "Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape": "7932109",
    "Superimmunity by pan-sarbecovirus nanobodies": "9174178",
    "Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity": "10865805",
    "Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines": "10170451",
    "Targeted photodynamic neutralization of SARS-CoV-2 mediated by singlet oxygen": "9906597",
    "The Development of a Novel Nanobody Therapeutic for SARS-CoV-2": "7685322",
    "The S2 subunit of spike encodes diverse targets for functional antibody responses to SARS-CoV-2": "11324185",
    "The SARS-CoV-2 spike glycoprotein interacts with MAO-B and impairs mitochondrial energetics": "10663135",
    "The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types": "7891930",
    "The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants": "9555207",
    "The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates": "8354634",
    "The role of single-domain antibodies (or nanobodies) in SARS-CoV-2 neutralization": "8514607",
    "The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape": "8920968",
    "Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?": "8890389",
    "Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses": "11140877",
    "Two birds with one stone: human SIRP\u03b1 nanobodies for functional modulation and in vivo imaging of myeloid cells": "10757926",
    "Two pan-SARS-CoV-2 nanobodies and their multivalent derivatives effectively prevent Omicron infections in mice": "9834170",
    "Uncovering a conserved vulnerability site in SARS\u2010CoV\u20102 by a human antibody": "8646660",
    "Unleashing the power of shark variable single domains (VNARs): broadly neutralizing tools for combating SARS-CoV-2": "10518403",
    "Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responses": "11666439",
    "Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions": "11679499",
    "Variation in structural motifs within SARS-related coronavirus spike proteins": "11236199",
    "Vero cell-adapted SARS-CoV-2 strain shows increased viral growth through furin-mediated efficient spike cleavage": "10986611"
}